Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 22711 AL 22725

Ketone body metabolism and the NLRP3 inflammasome in Alzheimer's disease

Shippy DC, Evered AH, Ulland TK.

Immunol Rev. 2025 Jan;329(1):e13365. doi: 10.1111/imr.13365. Epub 2024 Jul 11.

Gut Microbiota Mediates Neuroinflammation in Alzheimer's Disease: Unraveling Key Factors and Mechanistic Insights

Junyi L, Yueyang W, Bin L, Xiaohong D, Wenhui C, Ning Z, Hong Z.

Mol Neurobiol. 2025 Mar;62(3):3746-3763. doi: 10.1007/s12035-024-04513-w. Epub 2024 Sep 25.

Advanced nano delivery system for stem cell therapy for Alzheimer's disease

Pan Y, Li L, Cao N, Liao J, Chen H, Zhang M.

Biomaterials. 2025 Mar;314:122852. doi: 10.1016/j.biomaterials.2024.122852. Epub 2024 Sep 30.

Inflammatory signaling pathways in Alzheimer's disease: Mechanistic insights and possible therapeutic interventions

Almutary AG, Begum MY, Kyada AK, Gupta S, Jyothi SR, Chaudhary K, Sharma S, Sinha A, Abomughaid MM, Imran M, Lakhanpal S, Babalghith AO, Abu-Seer EA, Avinash D, Alzahrani HA, Alhindi AA, Iqbal D, Kumar S, Jha NK, Alghamdi S.

Ageing Res Rev. 2025 Feb;104:102548. doi: 10.1016/j.arr.2024.102548. Epub 2024 Oct 16.

Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer's disease

Karati D, Meur S, Roy S, Mukherjee S, Debnath B, Jha SK, Sarkar BK, Naskar S, Ghosh P.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2319-2342. doi: 10.1007/s00210-024-03500-1. Epub 2024 Oct 21.

Novel Emerging Targets Identification in Reducing Risk of Alzheimer's Disease

Sharma S, Rahate K, Kumar R.

Cent Nerv Syst Agents Med Chem. 2025;25(4):454-474. doi: 10.2174/0118715249333381241012073557.

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer's Pathogenesis

Almeida ZL, Vaz DC, Brito RMM.

Mol Neurobiol. 2025 Apr;62(4):4391-4419. doi: 10.1007/s12035-024-04543-4. Epub 2024 Oct 24.

Different physical exercise in the treatment of Alzheimer's disease

Deng T, Yu W, Lü Y.

Psychogeriatrics. 2025 Jan;25(1):e13207. doi: 10.1111/psyg.13207. Epub 2024 Oct 26.

Therapeutic Potential of Polyphenols in Cellular Reversal of Patho-Mechanisms of Alzheimer's Disease Using In Vitro and In Vivo Models: A Comprehensive Review

Samal M, Srivastava V, Khan M, Insaf A, Penumallu NR, Alam A, Parveen B, Ansari SH, Ahmad S.

Phytother Res. 2025 Jan;39(1):25-50. doi: 10.1002/ptr.8344. Epub 2024 Nov 4.

Amyloid-beta antibody treatment in Alzheimer's disease : An update on recent data and outlook on implementation in clinical routine

Stögmann E, Schmidt R.

Wien Klin Wochenschr. 2025 Mar;137(5-6):182-188. doi: 10.1007/s00508-024-02466-7. Epub 2024 Nov 6.

Application of carbon-based nanomaterials in Alzheimer's disease

Bai M, Shao X, Wang C, Wang J, Wang X, Guan P, Hu X.

Mater Horiz. 2025 Feb 3;12(3):673-693. doi: 10.1039/d4mh01256a.

The Contribution of the Renin-Angiotensin System to Alzheimer's Disease

Güzel Ö, Kehoe PG.

Curr Top Behav Neurosci. 2025;69:107-127. doi: 10.1007/7854_2024_525.

A review on gut microbiota and miRNA crosstalk: implications for Alzheimer's disease

Ayyanar MP, Vijayan M.

Geroscience. 2025 Feb;47(1):339-385. doi: 10.1007/s11357-024-01432-5. Epub 2024 Nov 19.

Exploring DPP IV inhibitors for Alzheimer's disease: Bridging diabetes and neurodegeneration

Pattanaik S, Prusty SK, Sahu PK.

Brain Res. 2025 Feb 1;1848:149342. doi: 10.1016/j.brainres.2024.149342. Epub 2024 Nov 19.

Calcium balance through mutual orchestrated inter-organelle communication: A pleiotropic target for combating Alzheimer's disease

Hossain MK, Chae HJ.

Neurochem Int. 2025 Jan;182:105905. doi: 10.1016/j.neuint.2024.105905. Epub 2024 Nov 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias